Communiqués Spineway

Actions

Marché Fermé - Euronext Paris Autres places de cotation 17:35:28 10/06/2024			Varia. 5j.	Varia. 1 janv.
0,7952 ^EUR	-2,38 %		-14,49 %	-88,31 %

17/04	Spineway : sanctionné malgré un premier trimestre solide	CF
17/04	Spineway : en croissance de 28% sur le 1er trimestre	AO

Partnership of Spineway with the SFCR for June 24 congress	18:01	AQ
Partnership with Key Opinion Leaders and successful trainings	30/05	AQ
Growth of 28% of 2024 first quarter revenue	16/04	AQ
2023 Shareholders General Meeting	26/03	AQ
Reverse stock split	29/02	AQ
Preparatory documents for the General Meeting as of of March 25, 2024	19/02	AQ
SPINEWAY : 2023 annual results	07/02	AQ
Increase of 2023 revenue at €10.5 million	25/01	AQ
Shares reverse split	05/01	AQ
SPINEWAY : International rollout of the VEOS implant range - First implants in Spain - New approvals in Colombia and Indonesia	24/11	AQ
Extraordinary General Meeting's minute	13/11	AQ
Deputy Chief Executive Officer's appointment	07/11	AQ
US 2023 NASS conference : VEOS System	02/11	AQ
Spineway : Document AMF CP. 2023E935253	27/10/23	PU
Spineway : Document AMF CP. 2023E934680	25/10/23	PU
Spineway : Document AMF CP. 2023E934420	24/10/23	PU
VEOS FDA 510(k) clearance	19/10/23	AQ
Spineway : Document AMF CP. 2023E933058	16/10/23	PU
Revenue growth as of September 2023 by 40%	13/10/23	AQ
INTERNATIONAL MASTERCLASS	14/09/23	AQ

Aucun résultat pour cette recherche